PSUSA/00002052/202410
PSUSA/00002052/202410
PSUSA/00002052/202410
Human medicines European public assessment report (EPAR): Targretin, bexarotene, Date of authorisation: 29/03/2001, Revision: 25, Status: Authorised
Human medicines European public assessment report (EPAR): Naveruclif, paclitaxel, Date of authorisation: 05/01/2024, Revision: 3, Status: Authorised
Human medicines European public assessment report (EPAR): Zometa, zoledronic acid, Date of authorisation: 20/03/2001, Revision: 40, Status: Authorised
European Medicines Agency Write PMS API implementation Guide (zip)
European Medicines Agency Write PMS API implementation Guide
Human medicines European public assessment report (EPAR): Jinarc, tolvaptan, Date of authorisation: 27/05/2015, Revision: 24, Status: Authorised
Human medicines European public assessment report (EPAR): Cystadrops, mercaptamine, Date of authorisation: 18/01/2017, Revision: 10, Status: Authorised
Product Management Services (PMS) - Implementation of International Organization for Standardization (ISO) standards for the identification of medicinal products (IDMP) in Europe - Chapter 2 - track changes
Product Management Services (PMS) - Implementation of International Organization for Standardization (ISO) standards for the identification of medicinal products (IDMP) in Europe - Chapter 2